Publication | Open Access
Comparison of Prognostic Scores in Patients With Hepatocellular Carcinoma Treated With Sorafenib
21
Citations
29
References
2021
Year
Although suboptimal, PROSASH-II is the most effective prognostic classification model among other available scores in a large Italian population of patients treated with sorafenib.
| Year | Citations | |
|---|---|---|
Page 1
Page 1